Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan
· Delayed Price · Currency is TWD 456.00
+3.50 (0.77%)
Mar 10, 2026, 11:28 AM CST
Bora Pharmaceuticals Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 56,121 | 77,712 | 64,612 | 31,121 | 12,446 | 10,634 | Upgrade
|
| Market Cap Growth | -35.19% | 20.27% | 107.61% | 150.04% | 17.05% | 89.60% | Upgrade
|
| Enterprise Value | 73,264 | 92,091 | 67,752 | 36,584 | 13,828 | 11,299 | Upgrade
|
| Last Close Price | 452.50 | 615.75 | 515.21 | 254.86 | 101.35 | 86.25 | Upgrade
|
| PE Ratio | 13.88 | 19.73 | 21.32 | 22.36 | 16.60 | 18.38 | Upgrade
|
| Forward PE | 11.68 | 16.07 | 21.03 | 11.57 | 15.18 | 21.75 | Upgrade
|
| PS Ratio | 2.66 | 4.04 | 4.55 | 2.97 | 2.54 | 5.91 | Upgrade
|
| PB Ratio | 3.58 | 5.18 | 5.49 | 6.05 | 3.95 | 4.31 | Upgrade
|
| P/TBV Ratio | 7.58 | 14.33 | 18.95 | 13.07 | 4.18 | 4.32 | Upgrade
|
| P/FCF Ratio | 26.86 | 171.66 | 14.97 | 17.14 | 11.60 | 372.33 | Upgrade
|
| P/OCF Ratio | 18.51 | 79.23 | 14.01 | 15.48 | 10.07 | 59.81 | Upgrade
|
| EV/Sales Ratio | 3.47 | 4.79 | 4.77 | 3.49 | 2.82 | 6.28 | Upgrade
|
| EV/EBITDA Ratio | 18.85 | 21.72 | 11.82 | 16.87 | 11.42 | 31.90 | Upgrade
|
| EV/EBIT Ratio | 26.13 | 27.23 | 12.91 | 19.03 | 13.22 | 49.98 | Upgrade
|
| EV/FCF Ratio | 35.06 | 203.42 | 15.70 | 20.15 | 12.89 | 395.62 | Upgrade
|
| Debt / Equity Ratio | 1.25 | 1.26 | 0.42 | 1.48 | 0.70 | 1.17 | Upgrade
|
| Debt / EBITDA Ratio | 4.66 | 4.36 | 0.86 | 3.44 | 1.80 | 7.88 | Upgrade
|
| Debt / FCF Ratio | 9.36 | 41.91 | 1.16 | 4.18 | 2.07 | 100.89 | Upgrade
|
| Net Debt / Equity Ratio | 0.96 | 0.87 | 0.14 | 0.79 | 0.42 | 0.90 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.70 | 3.08 | 0.28 | 1.88 | 1.08 | 6.24 | Upgrade
|
| Net Debt / FCF Ratio | 7.22 | 28.84 | 0.37 | 2.24 | 1.22 | 77.43 | Upgrade
|
| Asset Turnover | 0.48 | 0.54 | 0.59 | 0.70 | 0.68 | 0.35 | Upgrade
|
| Inventory Turnover | 3.03 | 3.01 | 3.48 | 5.19 | 3.16 | 1.56 | Upgrade
|
| Quick Ratio | 0.96 | 1.26 | 0.91 | 0.95 | 0.96 | 0.61 | Upgrade
|
| Current Ratio | 1.31 | 1.71 | 1.29 | 1.17 | 1.52 | 1.15 | Upgrade
|
| Return on Equity (ROE) | 29.02% | 30.18% | 36.34% | 33.80% | 26.69% | 28.09% | Upgrade
|
| Return on Assets (ROA) | 4.45% | 5.98% | 13.70% | 7.97% | 9.10% | 2.72% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.45% | 13.32% | 35.16% | 21.42% | 16.76% | 6.10% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.50% | 10.60% | 31.10% | 15.70% | 18.90% | 4.80% | Upgrade
|
| Earnings Yield | 5.49% | 5.07% | 4.69% | 4.47% | 6.02% | 5.44% | Upgrade
|
| FCF Yield | 3.72% | 0.58% | 6.68% | 5.83% | 8.62% | 0.27% | Upgrade
|
| Dividend Yield | 2.41% | 1.90% | 1.94% | 2.01% | 2.01% | 1.08% | Upgrade
|
| Payout Ratio | 47.02% | 31.30% | 20.43% | 17.16% | 14.64% | 14.39% | Upgrade
|
| Buyback Yield / Dilution | -2.02% | -8.17% | -4.93% | -1.41% | -0.86% | -7.55% | Upgrade
|
| Total Shareholder Return | 0.39% | -6.28% | -2.99% | 0.61% | 1.16% | -6.47% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.